Navigation Links
FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
Date:4/23/2008

Basingstoke, U.K. and Philadelphia, PA April 23, 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY,), the global specialty biopharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for VYVANSE (lisdexamfetamine dimesylate), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults. VYVANSE, introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, is now the first and only once-daily prodrug stimulant approved to treat adults with ADHD. In its first eight months of availability, more than one million VYVANSE prescriptions have been filled.

We are very pleased with this FDA approval of the adult indication for VYVANSE, said Matthew Emmens, Chief Executive Officer of Shire. This approval provides physicians a new treatment option that can help their adult patients by significantly improving their ADHD symptoms. VYVANSE has been well accepted by the medical community. With Shires experience as a leader in the development and commercialization of ADHD medications, we are confident that this approval for adult patients will help continue to increase prescription share and volume of VYVANSE.

Many people may think of ADHD as only a childhood disorder but the fact is that the majority of children diagnosed with ADHD still have symptoms as an adult. These symptoms can significantly impact them at work, home and in relationships, where they have important responsibilities, said David W. Goodman, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine and director of the Adult Attention Deficit Disorder Center of Maryland. The good news is that in a clinical study with adults, one daily dose of VYVANSE significantly improved ADHD symptoms of inattention, such as the ability to focus and organize, as well as hyperactivity and impulsivity.

Since VYVANSE became available for children with ADHD in
'/>"/>

Contact: Matthew Cabrey, Shire
484-595-8248
Porter Novelli
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Hawley, PA (PRWEB) January 22, 2015 Woodloch ... Pocono Mountains, has been selected by TripAdvisor as the number ... and the 6th best in the world for their annual ... online travel community . The website is home to ...
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... 22, 2015 Four years since the release of ... coincided with the marriage of Avasa & Matthew Love – the ... is scheduled for release through White Swan Records on February 24, ... is a sacred path available to all of us to walk ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... on findings of a recent study researchers say girls are ... explain this difference between girls and boys being diagnosed with ... conducting a study which aims to establish which children are ... or 5 years old who will be followed until they ...
... new study shows obese men generally have lower prostate specific ... say this finding suggests the PSA test may not be ... ,Researchers studied about 2,800 men with no evidence of ... The association held true across all age groups and throughout ...
... findings of a recent study researchers say obesity and ... formation.//Researchers believe larger body size causes increased urination of ... for calcium-containing kidney stones. ,The association between the ... mass index, and waist circumference was studied and results ...
... inhaled corticosteroid (budesonide) coupled with a long-acting beta2-agonist (formoterol) ... with less reliance on high doses of inhaled steroid, ... the study the effects of various combinations of medicine ... centers in 22 countries were analyzed. The patients were ...
... on findings of a recent study researchers say weight gain ... cancer risk for postmenopausal women who // are not taking ... 62,000 women, ages 50 to 74, by asking them about ... then, the women have been periodically asked to provide updates ...
... to be an autoimmune disorder, where white blood cells attack ... Statistics show that MS is twice as common in women ... weightlifting can help patients with multiple sclerosis. Since MS causes ... and a decreased quality of life, researchers designed an ...
Cached Medicine News:
(Date:1/23/2015)... new analysis of Centers for Medicare and Medicaid Services, ... 81 percent of seniors chose lower-cost preferred pharmacy plans ... pharmacies. The findings were released by Drug Channels ... foundation of Medicare Part D," said Pharmaceutical Care Management ...
(Date:1/23/2015)...  MedScope ( www.medscope.org ), the leading provider of medical ... Connected World magazine Connected World Award for its ... be used anywhere, anytime. The nomination was made by ... nominating MedScope, Landon Garner , Director of Marketing ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, ... Global Biotechnology, Inc. for the compounding, packaging and distributing of ... in the United States . ... capable of compounding naltrexone tablets in various strengths for individual ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... Nov. 9, 2010 Reportlinker.com announces that a new ... Cardiovascular Surgical Devices: The Global Market ... market for cardiovascular surgical devices used in the operating ... By 2015, this market will be valued at nearly ...
... Patients with ADD/ADHD -- NESS ZIONA, Israel, November 9, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Medicine Technology:Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 2Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 3Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 4Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 5Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 6Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 7Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 8Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 9Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 10Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 11Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 12Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 13Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 14Reportlinker Adds Cardiovascular Surgical Devices: The Global Market 15NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 2NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 3NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 4NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 5NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 6NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 7NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 8
Our Ophthalmic Diagnostic Sets offer everything an eye care specialist needs. Complete your set with your choice of ophthalmoscope, retinoscope, handle, and case....
3.5v Standard Ophthalmoscope Set with Convertible Handle and Soft Case. Our Standard Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Our 2.5v Streak Retinoscope Sets feature instruments with bright light, reliable handles, and convenient cases....
Medicine Products: